Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

[Granulosa cell tumors of the ovary].

[Granulosa cell tumors of the ovary]. Ovarian granulosa cell tumors (TGO) are rare neoplasms. They arise from sex cord stromal cells of the ovaries. They are characterized by their slow natural history, and their tendency to relapse long time after the initial diagnosis. Complete staging surgery of the disease is the cornerstone of treatment. Chemotherapy is indicated for localized tumors with a high risk of recurrence, and for recurrent or advanced tumors. Prolonged follow-up is recommended. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bulletin du cancer Pubmed

[Granulosa cell tumors of the ovary].

Bulletin du cancer , Volume 101 (1): 9 – Mar 21, 2014

[Granulosa cell tumors of the ovary].


Abstract

Ovarian granulosa cell tumors (TGO) are rare neoplasms. They arise from sex cord stromal cells of the ovaries. They are characterized by their slow natural history, and their tendency to relapse long time after the initial diagnosis. Complete staging surgery of the disease is the cornerstone of treatment. Chemotherapy is indicated for localized tumors with a high risk of recurrence, and for recurrent or advanced tumors. Prolonged follow-up is recommended.

Loading next page...
 
/lp/pubmed/granulosa-cell-tumors-of-the-ovary-TY2Ihwfy2b

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0007-4551
DOI
10.1684/bdc.2013.1879
pmid
24445864

Abstract

Ovarian granulosa cell tumors (TGO) are rare neoplasms. They arise from sex cord stromal cells of the ovaries. They are characterized by their slow natural history, and their tendency to relapse long time after the initial diagnosis. Complete staging surgery of the disease is the cornerstone of treatment. Chemotherapy is indicated for localized tumors with a high risk of recurrence, and for recurrent or advanced tumors. Prolonged follow-up is recommended.

Journal

Bulletin du cancerPubmed

Published: Mar 21, 2014

References